President & Chief Executive Officer, Board Member
Greg Madison has served as the company’s President and Chief Executive Officer since April 30, 2015, previously serving as its President and Chief Operating Officer. Mr. Madison joined Keryx in February 2014 from AMAG Pharmaceuticals (AMAG), where he was Executive Vice President and Chief Commercial Officer and in 2013 led the team to significant growth in net revenues.
Prior to AMAG, Mr. Madison spent 12 years at Genzyme/Sanofi developing extensive commercial and general management expertise as he progressed into roles of increasing responsibilities and leadership, culminating in his most recent role as Vice President and General Manager of the Renal division. In this role, Mr. Madison led a global organization with three marketed products with combined revenues exceeding $1 billion.
Mr. Madison’s prior experience in the Renal division included Vice President and General Manager of the U.S. business; Vice President of U.S. sales; and Vice President of U.S. marketing where he led all pre-launch preparation for Renvela®, the current leading phosphate binder in the U.S.
During his tenure with Genzyme, Mr. Madison also had roles in sales management, training, managed markets and reimbursement. Prior to joining Genzyme, Mr. Madison spent five years at Janssen Pharmaceuticals in sales and sales management roles, and began his career in the pharmaceutical industry in sales with Wyeth-Ayerst.
Mr. Madison currently serves on the Board of Trustees of the American Kidney Foundation and the Board of Advisors for Life Science Cares, a non-profit organization of life science leaders to help address the impact of poverty and inequality in Boston. He holds a Bachelor of Business Administration in Finance from the University of Massachusetts, Amherst.